Literature DB >> 24379156

Nothing to declare: mandatory and voluntary disclosure leads advisors to avoid conflicts of interest.

Sunita Sah1, George Loewenstein.   

Abstract

Professionals face conflicts of interest when they have a personal interest in giving biased advice. Mandatory disclosure--informing consumers of the conflict--is a widely adopted strategy in numerous professions, such as medicine, finance, and accounting. Prior research has shown, however, that such disclosures have little impact on consumer behavior, and can backfire by leading advisors to give even more biased advice. We present results from three experiments with real monetary stakes. These results show that, although disclosure has generally been found to be ineffective for dealing with unavoidable conflicts of interest, it can be beneficial when providers have the ability to avoid conflicts. Mandatory and voluntary disclosure can deter advisors from accepting conflicts of interest so that they have nothing to disclose except the absence of conflicts. We propose that people are averse to being viewed as biased, and that policies designed to activate reputational and ethical concerns will motivate advisors to avoid conflicts of interest.

Entities:  

Keywords:  conflicts of interest; decision making; disclosure; ethics; judgment; morality; policy making; social behavior

Mesh:

Year:  2013        PMID: 24379156     DOI: 10.1177/0956797613511824

Source DB:  PubMed          Journal:  Psychol Sci        ISSN: 0956-7976


  14 in total

1.  The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment.

Authors:  Alison R Hwong; Sunita Sah; Lisa Soleymani Lehmann
Journal:  J Gen Intern Med       Date:  2017-07-17       Impact factor: 5.128

2.  (Re)disclosing physician financial interests: rebuilding trust or making unreasonable burdens on physicians?

Authors:  Daniel Sperling
Journal:  Med Health Care Philos       Date:  2017-06

3.  Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.

Authors:  Deborah C Marshall; Beverly Moy; Madeleine E Jackson; Tim K Mackey; Jona A Hattangadi-Gluth
Journal:  J Natl Cancer Inst       Date:  2016-07-07       Impact factor: 13.506

4.  Effect of physician disclosure of specialty bias on patient trust and treatment choice.

Authors:  Sunita Sah; Angela Fagerlin; Peter Ubel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

5.  Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey.

Authors:  Marlene Stoll; Lara Hubenschmid; Cora Koch; Klaus Lieb; Boris Egloff
Journal:  BMJ Open       Date:  2022-06-24       Impact factor: 3.006

6.  Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review.

Authors:  Adrian M J Pokorny; Alice Fabbri; Lisa A Bero; Ray Moynihan; Barbara J Mintzes
Journal:  Br J Cancer       Date:  2021-10-01       Impact factor: 9.075

Review 7.  Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program.

Authors:  Deborah C Marshall; Madeleine E Jackson; Jona A Hattangadi-Gluth
Journal:  Mayo Clin Proc       Date:  2016-01       Impact factor: 7.616

8.  A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.

Authors:  Joel Lexchin; Adriane Fugh-Berman
Journal:  J Gen Intern Med       Date:  2021-03-10       Impact factor: 6.473

9.  Getting more light into the dark room of editorial conflicts of interest.

Authors:  Ana Marušić; Rafael Dal-Ré
Journal:  J Glob Health       Date:  2018-06       Impact factor: 4.413

10.  Conflicts of interest of editors of medical journals.

Authors:  Waqas Haque; Abu Minhajuddin; Arjun Gupta; Deepak Agrawal
Journal:  PLoS One       Date:  2018-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.